Medicines.
Non-exclusive medicinal product discount agreements according to § 130 a para. 8 sgb v with the option of concluding the active ingredient combination fusidic acid / betamethasone.
Non-exclusive medicinal product discount agreements according to § 130 a para. 8 sgb v with the option of concluding the active ingredient combination fusidic acid / betamethasone.
Classified in :
#Medicinal Product
#Medicine
#Fusidic Acid
#Betamethasone
Partner Opportunity
Key Location
Germany
Key Value
Worth :
Ref Doc
| EMD | : | Refer Document |
| Doc Fees | : | Refer Document |
Due on
31-Jul-2023
-957 Days Left
| Days to go | : | -957 Days |
| Opening on | : | Refer Document |
| Published on | : | 12-May-2021 |
